LGD-2226 是一种选择性和口服活性的雄激素受体 (AR) 调节剂,对人雄激素受体的EC50为 0.2 nM,Ki为 1.5 nM。LGD-2226 在动物模型中显示出组织选择性,与肌肉相比,对前列腺的作用较低。LGD-2226 可用于肌肉萎缩,骨质疏松和性功能障碍的研究。
All
Chemical Reagents
Biomedicine
Organic raw materials
Inorganic chemical industry
intermediate
Agricultural chemicals
Auxiliaries and catalysts
Fragrances and Flavors
Dyes and Pigments
Daily chemical industry
Lgd-2226
Dangerous GoodsCAS number:328947-93-9 molecular formula:C14H9F9N2O
overview
compound introduction
Specs
| Chinese alias | - | ||
| English alias | - | ||
| CAS number | 328947-93-9 | molecular formula | C14H9F9N2O |
| molecular weight | 392.22 g/mol | Exact mass | ≥98% |
| PSA | 32.299 Ų | logp | 4.1 |
numbering system
No numbering system information yet
physicochemical properties
No physical and chemical property information yet
Safety information
pictogram:
GHS08
Signal word:
Warning
Hazard Statement:
H373: 通过长时间或反复暴露对器官造成损害
Statement of Preventive Measures:
P501: 将内容物/容器处理到。。。 P260: 不要吸入灰尘/烟雾/气体/雾/蒸汽/喷雾。 P319: 如果你感到不适,请寻求医疗帮助。
Production methods and uses
No production method and use information yet
Related
upstream information
No upstream information yet
downstream information
No downstream information yet
MSDS
Found 1 shareMSDS
328947-93-9 | 6-[Bis(2,2,2-trifluoroethyl)amino]-4-(trifluoromethyl)-2(1H)-quin olinone.pdf





